These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 22266839

  • 21. Nanochemoprevention by bioactive food components: a perspective.
    Siddiqui IA, Mukhtar H.
    Pharm Res; 2010 Jun; 27(6):1054-60. PubMed ID: 20221894
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
    Ramesh N, Mandal AKA.
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1506-1514. PubMed ID: 31215261
    [Abstract] [Full Text] [Related]

  • 23. Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
    Granja A, Pinheiro M, Reis S.
    Nutrients; 2016 May 20; 8(5):. PubMed ID: 27213442
    [Abstract] [Full Text] [Related]

  • 24. Nano-encapsulation of epigallocatechin gallate in the ferritin-chitosan double shells: Simulated digestion and absorption evaluation.
    Yang R, Liu Y, Gao Y, Yang Z, Zhao S, Wang Y, Blanchard C, Zhou Z.
    Food Res Int; 2018 Jun 20; 108():1-7. PubMed ID: 29735037
    [Abstract] [Full Text] [Related]

  • 25. Enhancement of the permeability and activities of epigallocatechin gallate by quaternary ammonium chitosan/fucoidan nanoparticles.
    Huang TW, Ho YC, Tsai TN, Tseng CL, Lin C, Mi FL.
    Carbohydr Polym; 2020 Aug 15; 242():116312. PubMed ID: 32564860
    [Abstract] [Full Text] [Related]

  • 26. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
    Fangueiro JF, Andreani T, Fernandes L, Garcia ML, Egea MA, Silva AM, Souto EB.
    Colloids Surf B Biointerfaces; 2014 Nov 01; 123():452-60. PubMed ID: 25303852
    [Abstract] [Full Text] [Related]

  • 27. Fabrication of self-assembled (-)-epigallocatechin gallate (EGCG) ovalbumin-dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells.
    Li Z, Gu L.
    J Agric Food Chem; 2014 Feb 12; 62(6):1301-9. PubMed ID: 24446922
    [Abstract] [Full Text] [Related]

  • 28. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
    Silva AM, Martins-Gomes C, Fangueiro JF, Andreani T, Souto EB.
    Pharm Dev Technol; 2019 Dec 12; 24(10):1243-1249. PubMed ID: 31437118
    [Abstract] [Full Text] [Related]

  • 29. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
    Cano A, Ettcheto M, Chang JH, Barroso E, Espina M, Kühne BA, Barenys M, Auladell C, Folch J, Souto EB, Camins A, Turowski P, García ML.
    J Control Release; 2019 May 10; 301():62-75. PubMed ID: 30876953
    [Abstract] [Full Text] [Related]

  • 30. Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (-)-Epigallocatechin Gallate under Intestinal Tract Conditions.
    Liang R, Chen L, Yokoyama W, Williams PA, Zhong F.
    J Agric Food Chem; 2016 Dec 07; 64(48):9180-9188. PubMed ID: 27933988
    [Abstract] [Full Text] [Related]

  • 31. Active Targeted Nanoparticles for Oral Administration of Gastric Cancer Therapy.
    Lin YH, Chen ZR, Lai CH, Hsieh CH, Feng CL.
    Biomacromolecules; 2015 Sep 14; 16(9):3021-32. PubMed ID: 26286711
    [Abstract] [Full Text] [Related]

  • 32. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B, Ying H, Yu C, Fan Z, Zhang W, Shi J, Ying H, Ravichandran N, Xu Y, Yin J, Jiang Y, Du Q.
    Int J Pharm; 2016 Oct 15; 512(1):22-31. PubMed ID: 27544847
    [Abstract] [Full Text] [Related]

  • 33. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
    Sanna V, Singh CK, Jashari R, Adhami VM, Chamcheu JC, Rady I, Sechi M, Mukhtar H, Siddiqui IA.
    Sci Rep; 2017 Feb 01; 7():41573. PubMed ID: 28145499
    [Abstract] [Full Text] [Related]

  • 34. Sustained release of epigallocatechin-3-gallate from chitosan-based scaffolds to promote osteogenesis of mesenchymal stem cell.
    Wang J, Sun Q, Wei Y, Hao M, Tan WS, Cai H.
    Int J Biol Macromol; 2021 Apr 15; 176():96-105. PubMed ID: 33577812
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Target challenging-cancer drug delivery to gastric cancer tissues with a fucose graft epigallocatechin-3-gallate-gold particles nanocomposite approach.
    Yuan X, He Y, Zhou G, Li X, Feng A, Zheng W.
    J Photochem Photobiol B; 2018 Jun 15; 183():147-153. PubMed ID: 29705507
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
    Frias I, Neves AR, Pinheiro M, Reis S.
    Drug Des Devel Ther; 2016 Jun 15; 10():3519-3528. PubMed ID: 27826184
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems.
    Granja A, Frias I, Neves AR, Pinheiro M, Reis S.
    Biomed Res Int; 2017 Jun 15; 2017():5813793. PubMed ID: 28791306
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.